Skip to content
Browse

Edition

Sections

Appearance

AboutSourcesContactPrivacy

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

First reported by CNBC 1 source
Read at CNBC(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. CNBC

    Novo says Wegovy injection lowers BMI and obesity rates in children in trial (opens CNBC in a new tab)

    Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Something wrong with how we've grouped or summarised this story? Report a problem